Eyes On The Future
Charity Number: 1198330
Stay updated on changes from Eyes On The Future and other funders
Get daily notifications about new funding opportunities, deadline changes, and programme updates from UK funders.
Quick Stats
- Annual Giving: Not publicly disclosed (Total expenditure 2024: £133,099)
- Success Rate: Not applicable - no public application process
- Decision Time: Not applicable - partnership-based funding
- Grant Range: £50,000+ (majority of grants are large awards)
- Geographic Focus: International (funding research globally)
Contact Details
- Website: https://eyesonthefuture.org.uk
- Email: contact@eyesonthefuture.org.uk
- Phone: 7557322613
- Address: 10 Queen Street Place, London, EC4R 1BE
Overview
Eyes on the Future was officially incorporated as a UK charity in 2022 (Charity No. 1198330), evolving from "Through Vicky's Eyes" which started in 2017. The charity promotes health and advances education in relation to rare diseases, eye diseases and inherited retinal dystrophies, with a specific focus on understanding and developing treatments for RDH12 Leber Congenital Amaurosis (LCA). With an annual income of £441,562 (2024), the organization has raised over $1 million since inception and operates as part of the Global RDH12 Alliance alongside RDH12 Fund for Sight and Candle in the Dark.
Funding Priorities
Grant Programs
Eyes on the Future expects that the majority of its grants will be large awards of £50,000 and over. Current and past funded partnerships include:
- Opus Genetics: Co-developing RDH12 Gene Therapy program
- University of Pennsylvania: Developing full-field stimulus test platform
- UCL London: Drug repurposing for potential small molecule therapies (4-year grant in partnership with Retina UK and Moorfields Eye Charity)
- Astellas Therapeutics: Pre-clinical gene therapy work
- Odylia Therapeutics: Exploring gene therapy models
Priority Areas
- Pre-clinical and clinical research for RDH12 treatments
- Gene therapy development for inherited retinal dystrophies
- Disease modeling and mechanism studies
- Drug repurposing and small molecule therapies
- Clinical trial design and outcome measures for RDH12
What They Don't Fund
While not explicitly stated, the charity's narrow focus suggests they do not fund:
- General eye research unrelated to inherited retinal dystrophies
- Non-RDH12 related conditions
- General health or education projects outside their specific mission

Ready to write a winning application for Eyes On The Future?
Our AI helps you craft proposals that match their exact priorities. Save 10+ hours and increase your success rate.
Governance and Leadership
Trustees
- Silvia Cerolini (CEO): Mother of 8-year-old Vicky with RDH12, 16 years in consumer goods industry, currently works in life sciences focusing on rare disease diagnosis. Co-founder who started Through Vicky's Eyes with husband Enrico.
- Claudia Calori: Marketing professional with experience at Procter & Gamble, HEINEKEN, and Nike; currently VP of Marketing at Philips Personal Health
- Francesca Revelli: Senior director in investment banking with Master's in Economics from Bocconi University
- Sean Russell: Biotech executive specializing in cell and gene therapy, runs consultancy firm PrimeRA Pharma Partners
- Francesca Lazzarini (Secretary): Transaction Manager at Simpson Thacher & Bartlett LLP
Patient Advisory Board
Includes patients and carers from diverse backgrounds, providing lived experience perspective to guide research priorities.
Application Process and Timeline
How to Apply
This funder does not have a public application process. Grants are awarded through strategic partnerships and trustee-identified opportunities. Researchers interested in RDH12 research should contact the charity directly to explore potential collaboration.
Getting on Their Radar
- Attend RDH12 scientific workshops and conferences (Eyes on the Future hosted the first RDH12 scientific workshop in Baltimore in 2019)
- Collaborate with existing funded institutions (UCL, University of Pennsylvania, Opus Genetics)
- Participate in the Global RDH12 Alliance network
- Contact directly via email (contact@eyesonthefuture.org.uk) with research proposals aligned to RDH12
Decision Timeline
Not applicable - funding decisions are made through strategic partnership discussions rather than formal application cycles.
Success Rates
Not applicable - no competitive application process.
Reapplication Policy
Not applicable - partnership-based funding model.
Application Success Factors
Based on funded projects, Eyes on the Future prioritizes:
- Direct relevance to RDH12 inherited retinal dystrophy
- Collaborative approaches with potential for clinical translation
- Researchers with established expertise in gene therapy or retinal diseases
- Projects that advance the pathway toward treatments
- International collaborations that leverage global expertise
- Research that builds on or complements existing funded work
Key Takeaways for Grant Writers
- This is not a traditional grant-making charity with open calls - relationship building is essential
- Focus must be specifically on RDH12 or closely related inherited retinal dystrophies
- Partnership with established research institutions increases likelihood of funding
- The charity actively seeks to seed innovative research globally
- Funding decisions appear to be strategic and mission-driven rather than competitive
- Consider connecting with existing funded researchers for collaboration opportunities
- Patient-centered approach is valued - engagement with Patient Advisory Board perspective important
Similar Funders
These funders frequently fund the same charities:
- The Arts Council of England
- Cancer Research UK
- British Heart Foundation
- Academy of Medical Sciences
- Health Data Research UK
- The London Community Foundation
- The Goodman Foundation
- THE JOHN S COHEN FOUNDATION
- The Arts Foundation
- The Marandi Foundation
- Cockayne Grants for the Arts
- Mayor of London
- Medical Research Council
- INSPIRATIONS
- GLOBAL REACH
- IN THE GAME
- THE TOWN HALL
- Bloomberg
- Northern Trust
🎯 You've done the research. Now write an application they can't refuse.
Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.
Data privacy and security by default
Your organisation's past successful grants and experience
AI analysis of what reviewers want to see
A compelling draft application in 10 minutes instead of 10 hours
References
- Eyes on the Future official website: https://eyesonthefuture.org.uk
- Grants & Publications page: https://eyesonthefuture.org.uk/grants-publications/
- Our Team page: https://eyesonthefuture.org.uk/our-team/
- Charity Commission Register: https://register-of-charities.charitycommission.gov.uk/charity-details/?regid=1198330&subid=0
- Find that Charity database: https://findthatcharity.uk/orgid/GB-CHC-1198330
Frequently Asked Questions
What does Eyes On The Future fund?
Grant Programs Eyes on the Future expects that the majority of its grants will be large awards of £50,000 and over.
How much funding does Eyes On The Future provide?
Eyes On The Future provides grants ranging from £50,000+ (majority of grants are large awards), with total annual giving of approximately Not publicly disclosed (Total expenditure 2024: £133,099).
How do I contact Eyes On The Future?
Website: https://eyesonthefuture. org.
Is Eyes On The Future a registered charity?
Yes, Eyes On The Future is a registered charity with the Charity Commission (charity number 1198330). They serve organisations across 14 regions in the UK.
How do I apply to Eyes On The Future?
How to Apply This funder does not have a public application process. Grants are awarded through strategic partnerships and trustee-identified opportunities. Researchers interested in RDH12 research should contact the charity directly to explore potential collaboration.
Where is Eyes On The Future based?
Eyes On The Future is based in London. They fund organisations across 14 regions in the UK.